Search This Blog

Saturday, September 19, 2015

Once-Weekly for all


This paper was originally published here, in French. We provide the google translation for your convenience. Proper translation will come soon. Some practical aspects may differ where you live.

Once-Weekly for all

1/7 for all!

In my country ... There are no malignant shadow on the capsized boats.

Reportedly, the BREATHER success, publishing Leibowitch (94 Garches), 4 modes of reliefs (HYPO-DOLU, ICCARRE, BI-EBIT, Mono-IP) show that:
- There is no profile excluding patients relief. At most he will have to choose carefully.
- The single dose, weekly, is not an oddity reserved for those who have relations: it is 10% of ICCARRIENS.

There are not excluded ... All anyone can consider. The success is not guaranteed. Nor is guaranteed success in 7/7.

This demonstrates that Leibowitch, and Breather support, Foto and Faucy is that failure to cure a part (without doubt a minority or a minority) of patients, can cure half the entire population.

According ICCARRE and Breather, and the other, the pattern is funnel (in the most conservative estimate):
95% of patients can achieve the 5/7 (ICCARRE)
Of which 95% can pass the 4/7
Of which 95% can succeed 3/7
Of which 95% can pass the 2/7 (adding a NRTIs)
Of which 95% can succeed 1/7.

And if ICCARRE 1/7 does not suit you, there are still HYPO-DOLU.

Failing to fully heal some were partially healed all. It is less well, and yet ... It is perhaps even better: it has the advantage of being open to all:

Iccarre HIV cure HIV AIDS AIDS relief organization Leibowitch Efavirenz

Those who do not come under the scheme will ICCARRIEN, choice, change to HYPO-DOLU or more favorable combo or a less ambitious relief.

The article Leibowitch is definitive:
Iccarre HIV HIV Garches Leibowitch ANRS-4D exclusion criteria dosage

The same dispersion and the overall vulnerability of the non-selective sample of patients suggests a 4/7 rhythm applicability to many, if not all people, stable under cART; moreover excluding patients with resistance to multiple viruses prevent a combination of relief with 2 ARVs synergistic, in case their ICCARRE lacking.

For the vast majority, even for the bruised, the most capsized, there are solutions. And ICCARIEN relief is only one of them. The cleverest (or luckiest) of the 'new' patients outset position themselves on the most favorable combos.

There is therefore an optimization strategy of its entry in the treatment.

But even if one is not in the most ideal alignment of the stars, there is a way to reposition itself for successful therapeutic relief.

Who benefits from the relief?
Suppose the young, without other disease or medication, with no apparent side effect is hardly interested ... which act ...
But this profile is not a majority, contrary to what seem to forget those who stay warm in their cabin in Canada.
A wide choice of medicines, free, sophisticated techniques, redeemed, blood dosing: this is true in Canada. And this is true in Canada.
It's a shame ... The gray veil of indifference is the only shadow on the board.
The other, more exposed to on medication, the wrong-medication, to poly pharmacy, abused are much more numerous. Overdose is a plague of Egypt for the victims, those who make the ostrich.
For those who can benefit from it is a godsend.
That's because I'm overdose can I do the weekly outlet.
Overdosing is harmful to those who do not take advantage.
This Sunday is the day of HYPO-DOLU outlet.

There are no malignant shadow on the capsized boats.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.